Shopping Cart
Remove All
Your shopping cart is currently empty
Espindolol is a novel non-selective β blocker with central 5-HT1a and partial β2 receptor agonist effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $63 | 6-8 weeks | 6-8 weeks | |
| 5 mg | $149 | 6-8 weeks | 6-8 weeks | |
| 10 mg | $197 | 6-8 weeks | 6-8 weeks | |
| 25 mg | $352 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $529 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $797 | 6-8 weeks | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $164 | 6-8 weeks | 6-8 weeks |
| Description | Espindolol is a novel non-selective β blocker with central 5-HT1a and partial β2 receptor agonist effects. |
| In vivo | Placebo-treated rats progressively lost body weight (-15.5 ± 7.2 g), lean mass (-1.5 ± 4.2 g), and fat mass (-15.6 ± 2.7 g), while espindolol treatment increased body weight (+8.0 ± 6.1 g, p < 0.05), particularly lean mass (+43.4 ± 3.5 g, p < 0.001), and reduced fat mass further (-38.6 ± 3.4 g, p < 0.001). Anabolic/catabolic signaling was assessed in gastrocnemius muscle. Espindolol decreased proteasome and caspase-3 proteolytic activities by approximately 50 % (all p < 0.05)[1]. |
| Synonyms | MT-102, MT102, MT 102, AGI-001, AGI001, AGI 001 |
| Molecular Weight | 248.32 |
| Formula | C14H20N2O2 |
| Cas No. | 26328-11-0 |
| Smiles | CC(C)NC[C@H](O)COc1cccc2[nH]ccc12 |
| Relative Density. | 1.152g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (221.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (8.05 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.